Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention.

doi:10.1080/17482940902785474

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention.

Acute cardiac care - 1 Jan 2009

Syros George, Mehran Roxana, Weisz Giora, Kittas Christos, Moses Jeffrey W, Leon Martin, Dangas George

Abstract excerpt

OBJECTIVES: We examined the relationship between the PLA2 polymorphism of the platelet GPIIIa receptor and major adverse cardiac events (MACE) after percutaneous coronary intervention (PCI). BACKGROUND: PLA2 polymorphism has been associated with increased thrombosis and myocardial infarction. The association of PlA2 with MACE post-PCI has not been determined. METHODS: 200 patients with normal baseline CKMB...

Topics

Aged
Angioplasty, Balloon, Coronary
Antigens, Human Platelet
Coronary Artery Disease
DNA
Epitopes
Female
Follow-Up Studies
Gene Frequency
Genotype
Humans
Male
Middle Aged
Polymerase Chain Reaction
Polymorphism, Genetic
Postoperative Period
Prognosis
Prospective Studies

Source

Open in PubMed

Identifiers

PMID: 19526385
DOI: 10.1080/17482940902785474

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics